Phentolamine Mesylate — CAS 65-28-1

Phentolamine Mesylate is a non-selective, reversible alpha-adrenergic receptor blocker used in the management of hypertensive emergencies and pheochromocytoma. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. It blocks both alpha-1 and alpha-2 adrenoceptors, causing vasodilation and reduction of blood pressure. It is also used intravenously to reverse local anesthesia and in the treatment of erectile dysfunction.

• Hypertensive crisis management in pheochromocytoma surgery
• Prevention and treatment of dermal necrosis from norepinephrine extravasation
• Reversal of soft tissue anesthesia in dental and oral procedures
• Erectile dysfunction treatment (intracavernosal injection formulations)

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support